Synapse - Department of Medicine

Results (164)

Narsoplimab results in excellent survival in adults and children with hematopoietic cell transplant associated thrombotic microangiopathy (TA-TMA)

Journal Article

Schoettler, M. L.; Pusarla, S. K.; Nangia, N.; Perales, M.; Duarte, R. F.; Grauer, A.; Rambaldi, A.
American Journal of Hematology (2025)

Fulltext@MSK | Save

Integrative genomic and transcriptomic analysis reveals targetable vulnerabilities in angioimmunoblastic T-cell lymphoma

Journal Article

Bouska, A.; Zhang, W.; Sharma, S.; Holte, H.; Shah, R. A.; Lone, W. G.; Soma, M. A.; Yang, R.; Liu, X.; Mehmood, S.; more...
American Journal of Hematology (2025)

Fulltext@MSK | Save

Prognostic implication of karyotypic evaluation in patients with Richter transformation in the modern era

Research Letter

Miller, C. R.; Huang, Y.; Allan, J. N.; Bhat, S. A.; Bond, D.; Brander, D.; Byrd, J. C.; Chavez, J.; Chong, E.; Danilov, A.; more...
American Journal of Hematology (2025)

Fulltext@MSK | Save

Outcomes of reduced elective nodal radiation dose and volume for laryngeal, hypopharyngeal, and p16-negative oropharyngeal cancers

Journal Article

Zakeri, K.; Wren, S. D.; Shang, T.; Yu, Y.; Chen, L.; Shamseddine, A.; Safavi, A. H.; Kang, J. J.; Tsai, C. J.; Sherman, E. J.; more...
Head & Neck (2025)

Fulltext@MSK | Save

Venetoclax–azacitidine versus azacitidine for the treatment of primary refractory or first relapsed acute myeloid leukemia. An IPC-DATAML-MSKCC retrospective study

Correspondence

Petit, C.; Higue, J.; Acheaibi, Z.; Gilhodes, J.; Hospital, M. A.; Devillier, R.; Bewersdorf, J.; Goldberg, A. D.; Pigneux, A.; Vey, N.; more...
American Journal of Hematology (2025)

Fulltext@MSK | Save

BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study

Research Letter

Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
American Journal of Hematology (2025)

Fulltext@MSK | Save

Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study

Research Letter

Ghosh, N.; Eyre, T. A.; Brown, J. R.; Lamanna, N.; Manzoor, B. S.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C.; Leslie, L. A.; Roeker, L. E.; more...
American Journal of Hematology (2025)

Fulltext@MSK | Save

Outcomes of SMARCB1-deficient sinonasal carcinoma: Largest single-center cross-sectional study

Journal Article

Woods, R.; Scholfield, D.; Axiotakis, L.; Fitzgerald, C.; Adilbay, D.; Cracchiolo, J.; Patel, S.; Shah, J.; Dunn, L.; Pfister, D.; more...
Head & Neck (2024)

Fulltext@MSK | Save

Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial

Journal Article

Janopaul-Naylor, J. R.; Boe, L.; Yu, Y.; Sherman, E. J.; Pfister, D. G.; Lee, N. Y.; McBride, S.
Head & Neck (2024)

Fulltext@MSK | Save

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

Correspondence

Bewersdorf, J. P.; Shimony, S.; Shallis, R. M.; Liu, Y.; Berton, G.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A.; Stein, E.; Marcucci, G.; more...
American Journal of Hematology (2024)

Fulltext@MSK | Save